| Inductively coupled plasma optical emission spectrometry (ICP-OES): a powerful analytical technique for elemental analysis SR Khan, B Sharma, PA Chawla, R Bhatia Food Analytical Methods, 1-23, 2022 | 141 | 2022 |
| Thiophene-based derivatives as anticancer agents: An overview on decade’s work S Pathania, PA Chawla Bioorganic Chemistry 101, 104026, 2020 | 133 | 2020 |
| Clinical implications and treatment of dengue P Chawla, A Yadav, V Chawla Asian Pacific journal of tropical medicine 7 (3), 169-178, 2014 | 129 | 2014 |
| Targeted drug delivery: trends and perspectives S Ashique, NK Sandhu, V Chawla, PA Chawla Current drug delivery 18 (10), 1435-1455, 2021 | 91 | 2021 |
| An overview on medicinal perspective of thiazolidine-2, 4-dione: A remarkable scaffold in the treatment of type 2 diabetes G Bansal, PV Thanikachalam, RK Maurya, P Chawla, S Ramamurthy Journal of advanced research 23, 163-205, 2020 | 86 | 2020 |
| Fullerenes: from carbon to nanomedicine P Chawla, V Chawla, R Maheshwari, S A Saraf, S K Saraf Mini reviews in medicinal chemistry 10 (8), 662-677, 2010 | 82 | 2010 |
| Synthesis and biological evaluation of thiazolidine-2, 4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents G Bansal, S Singh, V Monga, PV Thanikachalam, P Chawla Bioorganic chemistry 92, 103271, 2019 | 70 | 2019 |
| Voltage gated sodium channel inhibitors as anticonvulsant drugs: A systematic review on recent developments and structure activity relationship studies R Pal, B Kumar, MJ Akhtar, PA Chawla Bioorganic Chemistry 115, 105230, 2021 | 53 | 2021 |
| Role of heterocyclic compounds in SARS and SARS CoV-2 pandemic M Negi, PA Chawla, A Faruk, V Chawla Bioorganic Chemistry 104, 104315, 2020 | 53 | 2020 |
| Medicinal perspective of quinazolinone derivatives: Recent developments and structure–activity relationship studies SK Wahan, B Sharma, PA Chawla Journal of Heterocyclic Chemistry 59 (2), 239-257, 2022 | 46 | 2022 |
| Synthesis and evaluation of thiazolidinedione-coumarin adducts as antidiabetic, anti-inflammatory and antioxidant agents G Mishra, N Sachan, P Chawla Letters in Organic Chemistry 12 (6), 429-455, 2015 | 45 | 2015 |
| Recent development in synthesis of carbon dots from natural Resources and their applications in biomedicine and multi‐sensing platform P Bag, RK Maurya, A Dadwal, M Sarkar, PA Chawla, RK Narang, ... ChemistrySelect 6 (11), 2774-2789, 2021 | 40 | 2021 |
| Effect of chloro and fluoro groups on the antimicrobial activity of 2, 5-disubstituted 4-thiazolidinones: a comparative study P Chawla, R Singh, SK Saraf Medicinal Chemistry Research 21, 3263-3271, 2012 | 39 | 2012 |
| Epidermal growth factor receptor inhibitors as potential anticancer agents: An update of recent progress B Sharma, VJ Singh, PA Chawla Bioorganic Chemistry 116, 105393, 2021 | 38 | 2021 |
| Syntheses and evaluation of 2, 5-disubstituted 4-thiazolidinone analogues as antimicrobial agents P Chawla, R Singh, SK Saraf Medicinal Chemistry Research 21, 2064-2071, 2012 | 37 | 2012 |
| Reactive metabolites of the anticonvulsant drugs and approaches to minimize the adverse drug reaction R Pal, K Singh, SA Khan, P Chawla, B Kumar, MJ Akhtar European Journal of Medicinal Chemistry 226, 113890, 2021 | 30 | 2021 |
| Bioactive flavonoids: A comprehensive review on pharmacokinetics and analytical aspects K Billowria, R Ali, NK Rangra, R Kumar, PA Chawla Critical Reviews in Analytical Chemistry 54 (5), 1002-1016, 2024 | 29 | 2024 |
| Advancements in the use of platinum complexes as anticancer agents R Sharma, VJ Singh, PA Chawla Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 28 | 2022 |
| Synthesis, biological evaluation and molecular docking studies of novel 3, 5-disubstituted 2, 4-thiazolidinediones derivatives AR Srivastava, R Bhatia, P Chawla Bioorganic chemistry 89, 102993, 2019 | 28 | 2019 |
| Rapid and sensitive HPLC-UV method for simultaneous estimation of Nifedipine, Nateglinide and Lovastatin: quantitative application to polypill based synthetic ternary mixture S Asthana, V Kaur, P Chawla, SA Saraf Int. J. Pharmtech. Res 2, 682-688, 2010 | 28 | 2010 |